MedTrace Logo

Circulating Tumor Cells in Prostate Cancer Patients

NCT01414712 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 2

Last updated 2020-08-20

No results posted yet for this study

Summary

The purpose of this study is to determine if a non-invasive cancer treatment, high-dose stereotactic body radiotherapy (SBRT), is associated with changes in circulating tumor cells counts in patients with low- and intermediate-risk prostate cancer.

Conditions

Interventions

OTHER

Blood Drawing

Blood Drawing to measure circulating tumor cells counts.

Sponsors & Collaborators

  • University of Texas Southwestern Medical Center

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-07-31
Primary Completion
2011-12-31
Completion
2011-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01414712 on ClinicalTrials.gov